{"schema_version":"secwatch.filing_event.v1","accession":"0001040130-26-000040","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2026-08-13T20:17:02+00:00","discovered_at":"2026-08-13T20:19:00.270617+00:00","generated_at":"2026-08-13T20:19:26.361040+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PetMed Express Q1 net sales down 19.9% to $41.0M; net loss narrows to $6.1M","bullets":["Net sales $41.0M vs $51.2M prior year, down 19.9% on lower prescription sales and reduced promotional usage.","Net loss $6.1M ($0.28/share) vs $34.2M ($1.65/share) loss prior year; improvement from no goodwill/trade name impairment.","Adjusted EBITDA $(3.4)M vs $(2.7)M prior year.","Acquired 70,000 new customers; cost per new customer down 15% YoY; G&A down ~14%.","Completed SAP ERP rollout; sale-leaseback transaction to strengthen balance sheet."],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-26-000040","json":"https://secwatch.observer/filing/0001040130-26-000040.json","markdown":"https://secwatch.observer/filing/0001040130-26-000040.md","text":"https://secwatch.observer/filing/0001040130-26-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000040/0001040130-26-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000040/pets-20260813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T20:19:26.361040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}